Clearline Capital LP Reduces Position in The Cooper Companies, Inc. $COO

Clearline Capital LP cut its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 89.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 40,636 shares of the medical device company’s stock after selling 339,454 shares during the period. Clearline Capital LP’s holdings in Cooper Companies were worth $3,331,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. New York Life Investment Management LLC increased its position in shares of Cooper Companies by 0.6% during the fourth quarter. New York Life Investment Management LLC now owns 27,344 shares of the medical device company’s stock valued at $2,241,000 after buying an additional 158 shares during the period. Root Financial Partners LLC increased its position in shares of Cooper Companies by 104.5% during the fourth quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock valued at $26,000 after buying an additional 162 shares during the period. Allworth Financial LP increased its position in shares of Cooper Companies by 14.1% during the fourth quarter. Allworth Financial LP now owns 1,355 shares of the medical device company’s stock valued at $111,000 after buying an additional 167 shares during the period. Mesirow Financial Investment Management Inc. increased its position in shares of Cooper Companies by 1.3% during the third quarter. Mesirow Financial Investment Management Inc. now owns 14,017 shares of the medical device company’s stock valued at $961,000 after buying an additional 175 shares during the period. Finally, Blue Trust Inc. increased its position in shares of Cooper Companies by 13.9% during the fourth quarter. Blue Trust Inc. now owns 1,515 shares of the medical device company’s stock valued at $124,000 after buying an additional 185 shares during the period. 24.39% of the stock is currently owned by institutional investors.

Cooper Companies Stock Down 3.4%

COO stock opened at $65.05 on Thursday. The company has a current ratio of 1.27, a quick ratio of 0.78 and a debt-to-equity ratio of 0.23. The company’s 50 day moving average is $64.58 and its 200 day moving average is $74.10. The stock has a market cap of $12.69 billion, a price-to-earnings ratio of 55.13, a price-to-earnings-growth ratio of 1.76 and a beta of 0.87. The Cooper Companies, Inc. has a 1-year low of $58.89 and a 1-year high of $89.83.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings data on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, topping the consensus estimate of $1.10 by $0.11. The company had revenue of $1.08 billion for the quarter, compared to analysts’ expectations of $1.05 billion. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. Cooper Companies’s revenue for the quarter was up 7.9% compared to the same quarter last year. During the same period in the prior year, the business earned $0.96 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Sell-side analysts predict that The Cooper Companies, Inc. will post 4.63 EPS for the current fiscal year.

Analysts Set New Price Targets

COO has been the topic of several analyst reports. Citigroup reiterated a “neutral” rating and set a $69.00 price target (down from $80.00) on shares of Cooper Companies in a research report on Thursday, May 28th. KeyCorp reiterated a “sector weight” rating on shares of Cooper Companies in a research report on Friday, June 5th. Needham & Company LLC decreased their price target on Cooper Companies from $101.00 to $86.00 and set a “buy” rating on the stock in a research report on Friday, June 5th. The Goldman Sachs Group set a $61.00 price target on Cooper Companies in a research report on Wednesday, May 27th. Finally, JPMorgan Chase & Co. decreased their price target on Cooper Companies from $80.00 to $71.00 and set a “neutral” rating on the stock in a research report on Friday, June 5th. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, five have issued a Hold rating and three have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $81.31.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.